All In Biotech

Free tool

FAERS Monitor: Myhibbin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 216482 or its brand name (Myhibbin, Mycophenolate Mofetil). Reports on generic versions are filed under their own applications.

Reports

106,242

Serious

99,414

94% of reports

Hospitalization

39,174

Death reported

20,488

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use16,486
  • drug ineffective10,406
  • product use in unapproved indication7,029
  • diarrhoea5,216
  • pyrexia4,594
  • cytomegalovirus infection4,470
  • pneumonia4,405
  • condition aggravated3,948
  • transplant rejection3,569
  • infection3,508
  • fatigue3,430
  • nausea3,309
  • vomiting3,101
  • acute kidney injury3,099
  • dyspnoea3,084

Reports by year received

View as table
YearReports
2004264
2005312
2006586
2007750
20081,013
20091,546
20101,368
20111,579
20121,528
20131,511
20141,774
20152,127
20162,666
20174,368
20186,301
20198,404
20209,582
20219,117
20228,343
20239,669
202412,352
202512,320
20268,757

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,947,917 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
transplant rejectionSignal3,569158.0151.3309,160
cytomegalovirus infectionSignal4,47072.470.0230,438
product use in unapproved indicationSignal7,0295.75.627,110
infectionSignal3,5084.94.710,671
acute kidney injurySignal3,0994.13.97,083
off label useSignal16,4863.83.734,500
pneumoniaSignal4,4052.72.64,786
pyrexiaSignal4,5942.72.64,735
condition aggravatedSignal3,9482.62.53,862
diarrhoea5,2161.61.61,215
drug ineffective10,4061.61.52,263
vomiting3,1011.31.3228
dyspnoea3,0841.11.018
fatigue3,4300.90.867
nausea3,3090.80.8124

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.